• (-)-Blebbistatin in Mechanomemory Assays

  2026-08-15

  Use (-)-Blebbistatin as a reversible non-muscle myosin II inhibitor to separate actomyosin-driven force transmission from F-actin remodeling in mechanotransduction experiments. This workflow connects intermittent mechanical loading with YAP localization, while offering practical controls for cytoskeletal dynamics research, migration assays, and contractility studies.

• BMS 599626 dihydrochloride Assay Guide

  2026-08-14

  A scenario-based guide to using BMS 599626 dihydrochloride (SKU B5792) for EGFR/ErbB2 pathway studies, cancer cell proliferation inhibition, and viability assay optimization. It connects biochemical potency, experimental controls, protocol planning, data interpretation, and practical product-selection criteria.

• Palmitic acid: Protocol, Solubility, and QC

  2026-08-14

  Palmitic acid (hexadecanoic acid, SKU N2456) provides a characterized saturated long-chain fatty acid for controlled in vitro work involving lipid metabolism, protein palmitoylation, and metabolic disorder research. It is unsuitable for direct aqueous preparation or long-term solution storage, so solvent selection, fresh preparation, and vehicle controls are central to reproducibility.

• Cyclic di-GMP Workflows for Biofilm and STING Studies

  2026-08-13

  Cyclic di-GMP connects bacterial biofilm persistence studies with STING-focused immune modulation research, but each application requires different delivery, controls, and readouts. This practical guide translates the reference study into reproducible workflows for biofilm formation regulation, genome stability assays, and cancer immunotherapy studies.

• Palmitic acid: Handling and Protocol Guidance

  2026-08-13

  Palmitic acid (SKU N2456) provides a defined saturated long-chain fatty acid input for controlled studies of lipid metabolism, insulin signaling, inflammation, and palmitoylation-related workflows. Because it is insoluble in water and solutions are not intended for long-term storage, solvent selection, fresh preparation, and vehicle controls are essential; it is not suitable for protocols requiring an intrinsically aqueous reagent.

• Trolox as a Redox Assay Calibration Tool

  2026-08-12

  Trolox is more than a generic antioxidant: it can help researchers distinguish lipid peroxidation control from broad reactive oxygen species suppression. This article connects Trolox assay design with ferroptosis biology, oxidative injury research, and reproducible translational workflows.

• CTDNEP1–NEP1R1 Control of ER Lipid Homeostasis

  2026-08-12

  This study shows that CTDNEP1 relies on NEP1R1 to remain stable and restrict endoplasmic reticulum expansion, whereas CTDNEP1 can limit lipid droplet formation without this regulatory subunit. By combining structure–function analysis, biochemical assays, modeling, and quantitative cell imaging, the authors establish that CTDNEP1 regulation is tailored to the distinct demands of membrane synthesis and lipid storage.

• SIRT1–PGC-1α–TFAM Protection in Prion-Stressed N2a

  2026-08-11

  Zhao et al. identify a SIRT1-dependent PGC-1α–TFAM pathway that restores mitochondrial biogenesis and reduces mitochondrial injury and apoptosis in PrP106–126-treated N2a cells. The study positions resveratrol as a pharmacological SIRT1 activator for mechanistic neuroprotection studies, while emphasizing the need for validation beyond this peptide-based cellular model.

• Disodium Bicinchoninate in Cardiac Fibrosis Assays

  2026-08-10

  Disodium bicinchoninate supports aqueous assay development for protein normalization and metal-responsive biochemical workflows without a DMSO or ethanol vehicle. Its practical value is especially clear when profiling high-glucose cardiomyocyte–fibroblast models linked to the cGMP/PKG pathway, provided the reagent is validated for the intended assay chemistry.

• Mitochondrial Permeability Transition Pore Assay Kit

  2026-08-09

  Discover how the Mitochondrial Permeability Transition Pore Assay Kit connects pore opening with ROS-driven mitochondrial injury and intrinsic apoptosis. This guide focuses on mechanistic interpretation, assay controls, and evidence-based decisions for cell death research.

• Dlin-MC3-DMA: Practical LNP RNA Delivery Guide

  2026-08-08

  Dlin-MC3-DMA is an ionizable cationic liposome lipid for building reproducible LNPs that carry siRNA or mRNA into cells. This guide connects formulation setup, hepatic gene silencing, mRNA vaccine formulation, assay controls, and troubleshooting with machine-learning insights from a published reference study.

• G007-LK Tankyrase 1/2 Inhibitor Guide

  2026-08-07

  G007-LK is a selective tankyrase 1/2 inhibitor for mechanistic studies of Wnt/β-catenin signaling, Hippo-YAP regulation, and cancer biology. Biochemical, cellular, and xenograft data support its use in APC mutation colorectal cancer research and related preclinical models, but the compound remains a research tool rather than a clinical treatment.

• Ginsenoside Rg1 Restores Gut-Immune-Brain Axis After Anesthe

  2026-08-07

  The reference study demonstrates that Ginsenoside Rg1, a triterpene saponin from Panax ginseng, reverses neuroimmune disruptions and cognitive deficits caused by prolonged isoflurane anesthesia in mice. The findings provide direct evidence for Treg-mediated gut-immune-brain axis restoration as a novel strategy for neuroprotection in perioperative and neurodegenerative research.

• EMD638683: SGK1 Inhibition for Vascular and Cancer Research

  2026-08-06

  Explore the strategic role of EMD638683, a selective SGK1 inhibitor, in unraveling the mechanisms of vascular stiffening and cancer progression. Grounded in recent mechanistic evidence and translational models, this article provides actionable insights for researchers leveraging SGK1 inhibition in high-impact disease workflows.

• 2-NBDG: Transforming Glucose Uptake Assays in Cancer Researc

  2026-08-06

  2-NBDG, a fluorescent glucose analog, empowers researchers to quantify cellular glucose uptake with unmatched sensitivity and versatility across cancer and metabolic disease models. Discover optimized workflows, troubleshooting insights, and the latest protocol enhancements that make 2-NBDG the gold standard for dynamic glucose metabolism assays.

453 records 8/31 page Previous Next First page 上5页 678910 下5页 Last page